{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T19:48:22Z","timestamp":1791920902716,"version":"4.3.4"},"reference-count":138,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["MOST-106-2320-B-006-037-MY3"],"award-info":[{"award-number":["MOST-106-2320-B-006-037-MY3"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","pathologyjournal.rcpa.edu.au","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.pathol.2019.09.005","type":"journal-article","created":{"date-parts":[[2019,11,5]],"date-time":"2019-11-05T05:30:42Z","timestamp":1572931842000},"page":"154-165","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":83,"title":["Hodgkin lymphoma: a review of pathological features and recent advances in pathogenesis"],"prefix":"10.1016","volume":"52","author":[{"given":"Miguel A.","family":"Piris","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6577-8006","authenticated-orcid":false,"given":"L. Jeffrey","family":"Medeiros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9665-5236","authenticated-orcid":false,"given":"Kung-Chao","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pathol.2019.09.005_bib1","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S1470-2045(03)01320-2","article-title":"Part II: Hodgkin's lymphoma--diagnosis and treatment","volume":"5","author":"Diehl","year":"2004","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.pathol.2019.09.005_bib2","series-title":"Rosai and Ackerman's Surgical Pathology","first-page":"1807","author":"Rosai","year":"2011"},{"key":"10.1016\/j.pathol.2019.09.005_bib3","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/nrc2542","article-title":"The biology of Hodgkin's lymphoma","volume":"9","author":"Kuppers","year":"2009","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.pathol.2019.09.005_bib4","series-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","year":"2017"},{"key":"10.1016\/j.pathol.2019.09.005_bib5","first-page":"439","article-title":"Cell cycle and apoptosis deregulation in classical Hodgkin lymphomas","volume":"19","author":"Bai","year":"2005","journal-title":"In\u00a0Vivo"},{"key":"10.1016\/j.pathol.2019.09.005_bib6","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/modpathol.3800276","article-title":"Aberrant expression of cell cycle regulators in Hodgkin and Reed-Sternberg cells of classical Hodgkin's lymphoma","volume":"18","author":"Tzankov","year":"2005","journal-title":"Mod Pathol"},{"key":"10.1016\/j.pathol.2019.09.005_bib7","doi-asserted-by":"crossref","first-page":"4287","DOI":"10.1182\/blood.V92.11.4287","article-title":"Generation of cells with Hodgkin's and Reed-Sternberg phenotype through downregulation of CD99 (Mic2)","volume":"92","author":"Kim","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2019.09.005_bib8","first-page":"947","article-title":"Expression of the LMP1 oncoprotein in the EBV negative Hodgkin's disease cell line L-428 is associated with Reed-Sternberg cell morphology","volume":"13","author":"Knecht","year":"1996","journal-title":"Oncogene"},{"key":"10.1016\/j.pathol.2019.09.005_bib9","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1182\/blood.V84.4.1005.1005","article-title":"The cellular biology of the Reed-Sternberg cell","volume":"84","author":"Haluska","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2019.09.005_bib10","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1172\/JCI200316624","article-title":"Identification of Hodgkin and Reed-Sternberg cell-specific genes by gene expression profiling","volume":"111","author":"Kuppers","year":"2003","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.pathol.2019.09.005_bib11","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1182\/blood-2002-03-0839","article-title":"Loss of the B-lineage-specific gene expression program in Hodgkin and Reed-Sternberg cells of Hodgkin lymphoma","volume":"101","author":"Schwering","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2019.09.005_bib12","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1182\/blood.V95.4.1443.004k55_1443_1450","article-title":"Hodgkin and Reed-Sternberg cells represent an expansion of a single clone originating from a germinal center B-cell with functional immunoglobulin gene rearrangements but defective immunoglobulin transcription","volume":"95","author":"Marafioti","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2019.09.005_bib13","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1182\/blood-2005-09-3765","article-title":"Epigenetic processes play a major role in B-cell-specific gene silencing in classical Hodgkin lymphoma","volume":"107","author":"Ushmorov","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2019.09.005_bib14","doi-asserted-by":"crossref","first-page":"3326","DOI":"10.1182\/blood-2003-04-1197","article-title":"Epigenetic silencing of the immunoglobulin heavy-chain gene in classical Hodgkin lymphoma-derived cell lines contributes to the loss of immunoglobulin expression","volume":"104","author":"Ushmorov","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2019.09.005_bib15","doi-asserted-by":"crossref","first-page":"4553","DOI":"10.1182\/blood-2004-12-4750","article-title":"From Hodgkin disease to Hodgkin lymphoma: biologic insights and therapeutic potential","volume":"105","author":"Re","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2019.09.005_bib16","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1093\/infdis\/146.4.506","article-title":"The biology and chemistry of Epstein-Barr virus","volume":"146","author":"Kieff","year":"1982","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.pathol.2019.09.005_bib17","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1128\/CMR.00044-10","article-title":"Progress and problems in understanding and managing primary Epstein-Barr virus infections","volume":"24","author":"Odumade","year":"2011","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.pathol.2019.09.005_bib18","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.jcv.2018.03.001","article-title":"Primary Epstein-Barr virus infection","volume":"102","author":"Dunmire","year":"2018","journal-title":"J\u00a0Clin Virol"},{"key":"10.1016\/j.pathol.2019.09.005_bib19","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/nrc1452","article-title":"Epstein-Barr virus: 40 years on","volume":"4","author":"Young","year":"2004","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.pathol.2019.09.005_bib20","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/35095584","article-title":"Epstein-Barr virus: exploiting the immune system","volume":"1","author":"Thorley-Lawson","year":"2001","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.pathol.2019.09.005_bib21","doi-asserted-by":"crossref","first-page":"5194","DOI":"10.1128\/JVI.78.10.5194-5204.2004","article-title":"Acute infection with Epstein-Barr virus targets and overwhelms the peripheral memory B-cell compartment with resting, latently infected cells","volume":"78","author":"Hochberg","year":"2004","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.pathol.2019.09.005_bib22","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1056\/NEJM198902233200806","article-title":"Detection of Epstein-Barr viral genomes in Reed-Sternberg cells of Hodgkin's disease","volume":"320","author":"Weiss","year":"1989","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.pathol.2019.09.005_bib23","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1001\/jama.1970.03170260036009","article-title":"A\u00a0seroepidemiologic study of infectious mononucleosis. The development of EB virus antibody in a military population","volume":"212","author":"Lehane","year":"1970","journal-title":"JAMA"},{"key":"10.1016\/j.pathol.2019.09.005_bib24","first-page":"689","article-title":"Social class and age at diagnosis of Hodgkin's disease: new epidemiologic evidence for the \"two-disease hypothesis","volume":"66","author":"Gutensohn","year":"1982","journal-title":"Cancer Treat Rep"},{"key":"10.1016\/j.pathol.2019.09.005_bib25","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1056\/NEJMoa023141","article-title":"Characteristics of Hodgkin's lymphoma after infectious mononucleosis","volume":"349","author":"Hjalgrim","year":"2003","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.pathol.2019.09.005_bib26","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1182\/asheducation.V2012.1.328.3798326","article-title":"New insights in the biology of Hodgkin lymphoma","volume":"2012","author":"Kuppers","year":"2012","journal-title":"Hematol Am Soc Hematol Educ Program"},{"key":"10.1016\/j.pathol.2019.09.005_bib27","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1182\/blood.V81.2.462.462","article-title":"Epstein-Barr virus and childhood Hodgkin's disease in Honduras and the United States","volume":"81","author":"Ambinder","year":"1993","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2019.09.005_bib28","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1097\/PAS.0000000000000107","article-title":"EBV may be expressed in the LP cells of nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) in both children and adults","volume":"38","author":"Huppmann","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.pathol.2019.09.005_bib29","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/S0344-0338(11)80897-6","article-title":"Frequent detection of Epstein-Barr virus (EBV), EBER transcripts and latent membrane protein-1 (LMP-1) in tumor cells in Hodgkin's disease arising in childhood","volume":"190","author":"Kanavaros","year":"1994","journal-title":"Pathol Res Pract"},{"key":"10.1016\/j.pathol.2019.09.005_bib30","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1002\/path.1711680405","article-title":"Epstein-Barr virus (EBV) and Hodgkin's disease in children: incidence of EBV latent membrane protein in malignant cells","volume":"168","author":"Weinreb","year":"1992","journal-title":"J\u00a0Pathol"},{"key":"10.1016\/j.pathol.2019.09.005_bib31","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1080\/10428194042000198849","article-title":"Distribution and prognosis of WHO lymphoma subtypes in Taiwan reveals a low incidence of germinal-center derived tumors","volume":"45","author":"Chang","year":"2004","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.pathol.2019.09.005_bib32","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1007\/s12185-016-2007-1","article-title":"Clinical features and outcomes of 139 Japanese patients with Hodgkin lymphoma","volume":"104","author":"Makita","year":"2016","journal-title":"Int J Hematol"},{"key":"10.1016\/j.pathol.2019.09.005_bib33","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000012120","article-title":"Epidemiologic characteristics of malignant lymphoma in Hubei, China: a single-center 5-year retrospective study","volume":"97","author":"Meng","year":"2018","journal-title":"Medicine (Baltimore)"},{"issue":"1 Suppl","key":"10.1016\/j.pathol.2019.09.005_bib34","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1002\/1097-0142(19950101)75:1+<357::AID-CNCR2820751318>3.0.CO;2-A","article-title":"Hodgkin's disease","volume":"75","author":"Medeiros","year":"1995","journal-title":"Cancer"},{"key":"10.1016\/j.pathol.2019.09.005_bib35","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.humpath.2005.05.003","article-title":"Epstein-Barr virus is associated with all histological subtypes of Hodgkin lymphoma in Vietnamese children with special emphasis on the entity of lymphocyte predominance subtype","volume":"36","author":"Chang","year":"2005","journal-title":"Hum Pathol"},{"key":"10.1016\/j.pathol.2019.09.005_bib36","doi-asserted-by":"crossref","first-page":"335","DOI":"10.3109\/inf.1983.15.issue-4.03","article-title":"Prevalence of antibodies to Epstein-Barr virus (EBV) in childhood and adolescence in Denmark","volume":"15","author":"Hesse","year":"1983","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.pathol.2019.09.005_bib37","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1093\/infdis\/131.4.403","article-title":"Seroepidemiologic study of Epstein-Barr virus infections in a rural community","volume":"131","author":"Sumaya","year":"1975","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.pathol.2019.09.005_bib38","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1002\/ijc.2910080203","article-title":"Epidemiologic patterns of Hodgkin's disease","volume":"8","author":"Correa","year":"1971","journal-title":"Int J Cancer"},{"key":"10.1016\/j.pathol.2019.09.005_bib39","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1056\/NEJM198101153040302","article-title":"Childhood social environment and Hodgkin's disease","volume":"304","author":"Gutensohn","year":"1981","journal-title":"N\u00a0Engl J Med"},{"issue":"Suppl 5","key":"10.1016\/j.pathol.2019.09.005_bib40","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1093\/annonc\/9.suppl_5.S45","article-title":"The many faces of Hodgkin's disease around the world: what have we learned from its pathology?","volume":"9","author":"Harris","year":"1998","journal-title":"Ann Oncol"},{"key":"10.1016\/j.pathol.2019.09.005_bib41","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1111\/j.1349-7006.2007.00667.x","article-title":"Changing patterns in the frequency of Hodgkin lymphoma subtypes and Epstein-Barr virus association in Taiwan","volume":"99","author":"Chang","year":"2008","journal-title":"Cancer Sci"},{"key":"10.1016\/j.pathol.2019.09.005_bib42","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1002\/ijc.23504","article-title":"Changing patterns of Hodgkin lymphoma incidence in Singapore","volume":"123","author":"Hjalgrim","year":"2008","journal-title":"Int J Cancer"},{"key":"10.1016\/j.pathol.2019.09.005_bib43","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1111\/his.13085","article-title":"Epstein-Barr virus latent membrane protein-1 up-regulates cytokines and correlates with older age and poorer prognosis in Hodgkin lymphoma","volume":"70","author":"Chang","year":"2017","journal-title":"Histopathology"},{"key":"10.1016\/j.pathol.2019.09.005_bib44","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.1365-2141.2004.04902.x","article-title":"Epstein-Barr virus-associated Hodgkin's lymphoma","volume":"125","author":"Gandhi","year":"2004","journal-title":"Br J Haematol"},{"key":"10.1016\/j.pathol.2019.09.005_bib45","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1136\/jcp.44.10.844","article-title":"Detection of Epstein-Barr virus genomes in Hodgkin's disease: relation to age","volume":"44","author":"Jarrett","year":"1991","journal-title":"J\u00a0Clin Pathol"},{"key":"10.1016\/j.pathol.2019.09.005_bib46","doi-asserted-by":"crossref","first-page":"5893","DOI":"10.4049\/jimmunol.168.11.5893","article-title":"Lack of antibody production following immunization in old age: association with CD8(+)CD28(-) T cell clonal expansions and an imbalance in the production of Th1 and Th2 cytokines","volume":"168","author":"Saurwein-Teissl","year":"2002","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.pathol.2019.09.005_bib47","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1046\/j.1365-2141.2001.02767.x","article-title":"Marked decrease in the Epstein-Barr virus positivity rate in nodular sclerosis subtype Hodgkin's disease in Tokyo: trend between 1955 and 1999","volume":"113","author":"Takeuchi","year":"2001","journal-title":"Br J Haematol"},{"key":"10.1016\/j.pathol.2019.09.005_bib48","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1053\/j.seminhematol.2016.05.009","article-title":"Nodular lymphocyte-predominant Hodgkin lymphoma","volume":"53","author":"Savage","year":"2016","journal-title":"Semin Hematol"},{"key":"10.1016\/j.pathol.2019.09.005_bib49","doi-asserted-by":"crossref","first-page":"3567","DOI":"10.1182\/blood-2013-12-541078","article-title":"Advanced-stage nodular lymphocyte predominant Hodgkin lymphoma compared with classical Hodgkin lymphoma: a matched pair outcome analysis","volume":"123","author":"Xing","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2019.09.005_bib50","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1097\/00000478-200312000-00003","article-title":"Peripheral T-cell lymphomas expressing CD30 and CD15","volume":"27","author":"Barry","year":"2003","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.pathol.2019.09.005_bib51","doi-asserted-by":"crossref","first-page":"4626","DOI":"10.1200\/JCO.2006.06.5342","article-title":"Prognostic significance of T-cell or cytotoxic molecules phenotype in classical Hodgkin's lymphoma: a clinicopathologic study","volume":"24","author":"Asano","year":"2006","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.pathol.2019.09.005_bib52","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/j.1365-2559.2009.03462.x","article-title":"BOB.1, CD79a and cyclin E are the most appropriate markers to discriminate classical Hodgkin's lymphoma from primary mediastinal large B-cell lymphoma","volume":"56","author":"Hoeller","year":"2010","journal-title":"Histopathology"},{"key":"10.1016\/j.pathol.2019.09.005_bib53","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/B978-0-12-364933-1.50007-2","article-title":"Diagnosis and grading of nodular sclerosing Hodgkin's disease: a study of 2190 patients","volume":"33","author":"MacLennan","year":"1992","journal-title":"Int Rev Exp Pathol"},{"key":"10.1016\/j.pathol.2019.09.005_bib54","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.clml.2016.11.004","article-title":"Improving survival of patients with Hodgkin lymphoma over 4 decades: experience of the British National Lymphoma Investigation (BNLI) with 6834 patients","volume":"17","author":"Kwan","year":"2017","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"10.1016\/j.pathol.2019.09.005_bib55","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1097\/00000478-198607000-00004","article-title":"The \"syncytial variant\" of nodular sclerosing Hodgkin's disease","volume":"10","author":"Strickler","year":"1986","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.pathol.2019.09.005_bib56","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1177\/2040620716676256","article-title":"Differences in outcome of patients with syncytial variant Hodgkin lymphoma compared with typical nodular sclerosis Hodgkin lymphoma","volume":"8","author":"Sethi","year":"2017","journal-title":"Ther Adv Hematol"},{"key":"10.1016\/j.pathol.2019.09.005_bib57","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.1182\/bloodadvances.2017009472","article-title":"Clinicopathologic consensus study of gray zone lymphoma with features intermediate between DLBCL and classical HL","volume":"1","author":"Pilichowska","year":"2017","journal-title":"Blood Adv"},{"key":"10.1016\/j.pathol.2019.09.005_bib58","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1200\/JCO.2017.76.0793","article-title":"Nivolumab for relapsed\/refractory classic Hodgkin lymphoma after failure of autologous hematopoietic cell transplantation: extended follow-up of the multicohort single-arm phase II CheckMate 205 trial","volume":"36","author":"Armand","year":"2018","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.pathol.2019.09.005_bib59","doi-asserted-by":"crossref","DOI":"10.3324\/haematol.2019.215962","article-title":"PD-1 blockade as bridge to allogenic stem cell transplantation in relapsed\/refractory Hodgkin lymphoma patients: a retrospective single center case series","author":"Casadei","year":"2019","journal-title":"Haematologica"},{"key":"10.1016\/j.pathol.2019.09.005_bib60","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1038\/modpathol.2009.54","article-title":"Lymphocyte-rich classical Hodgkin's lymphoma: distinctive tumor and microenvironment markers","volume":"22","author":"Nam-Cha","year":"2009","journal-title":"Mod Pathol"},{"key":"10.1016\/j.pathol.2019.09.005_bib61","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.anndiagpath.2014.03.007","article-title":"Epstein-Barr virus-positive nodular lymphocyte predominant Hodgkin lymphoma","volume":"18","author":"Wang","year":"2014","journal-title":"Ann Diagn Pathol"},{"key":"10.1016\/j.pathol.2019.09.005_bib62","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1097\/PAS.0b013e318165b0d6","article-title":"PD-1, a follicular T-cell marker useful for recognizing nodular lymphocyte-predominant Hodgkin lymphoma","volume":"32","author":"Nam-Cha","year":"2008","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.pathol.2019.09.005_bib63","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1056\/NEJM199510053331403","article-title":"Hodgkin's disease with monoclonal and polyclonal populations of Reed-Sternberg cells","volume":"333","author":"Hummel","year":"1995","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.pathol.2019.09.005_bib64","first-page":"72","article-title":"Cytogenetic findings and results of combined immunophenotyping and karyotyping in Hodgkin's disease","volume":"8","author":"Schlegelberger","year":"1994","journal-title":"Leukemia"},{"key":"10.1016\/j.pathol.2019.09.005_bib65","first-page":"549","article-title":"Genomic imbalances including amplification of the tyrosine kinase gene JAK2 in CD30+ Hodgkin cells","volume":"60","author":"Joos","year":"2000","journal-title":"Cancer Res"},{"key":"10.1016\/j.pathol.2019.09.005_bib66","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.1200\/JCO.2016.66.4482","article-title":"PD-L1 and PD-L2 genetic alterations define classical Hodgkin lymphoma and predict outcome","volume":"34","author":"Roemer","year":"2016","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.pathol.2019.09.005_bib67","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1158\/1078-0432.CCR-16-1387","article-title":"Nivolumab in the treatment of Hodgkin lymphoma","volume":"23","author":"Ansell","year":"2017","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.pathol.2019.09.005_bib68","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1159\/000058523","article-title":"The role of Epstein-Barr virus in neoplastic transformation","volume":"60","author":"Knecht","year":"2001","journal-title":"Oncology"},{"key":"10.1016\/j.pathol.2019.09.005_bib69","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/j.1349-7006.2010.01765.x","article-title":"Dominant expression of survival signals of endoplasmic reticulum stress response in Hodgkin lymphoma","volume":"102","author":"Chang","year":"2011","journal-title":"Cancer Sci"},{"key":"10.1016\/j.pathol.2019.09.005_bib70","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1038\/sj.onc.1202365","article-title":"Relationship between IkappaBalpha constitutive expression, TNFalpha synthesis, and apoptosis in EBV-infected lymphoblastoid cells","volume":"17","author":"Asso-Bonnet","year":"1998","journal-title":"Oncogene"},{"key":"10.1016\/j.pathol.2019.09.005_bib71","doi-asserted-by":"crossref","first-page":"7098","DOI":"10.1128\/MCB.16.12.7098","article-title":"Association of TRAF1, TRAF2, and TRAF3 with an Epstein-Barr virus LMP1 domain important for B-lymphocyte transformation: role in NF-kappaB activation","volume":"16","author":"Devergne","year":"1996","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.pathol.2019.09.005_bib72","doi-asserted-by":"crossref","first-page":"4339","DOI":"10.1182\/blood-2005-06-2341","article-title":"Rescue of \"crippled\" germinal center B cells from apoptosis by Epstein-Barr virus","volume":"106","author":"Mancao","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2019.09.005_bib73","first-page":"2982","article-title":"Latent membrane protein 1 is critical for efficient growth transformation of human B cells by epstein-barr virus","volume":"63","author":"Dirmeier","year":"2003","journal-title":"Cancer Res"},{"key":"10.1016\/j.pathol.2019.09.005_bib74","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1038\/sj.onc.1208367","article-title":"Latent membrane protein 1 of Epstein-Barr virus coordinately regulates proliferation with control of apoptosis","volume":"24","author":"Dirmeier","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/j.pathol.2019.09.005_bib75","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1038\/sj.onc.1202144","article-title":"Epstein-Barr virus latent membrane protein-1 (LMP1) signalling is distinct from CD40 and involves physical cooperation of its two C-terminus functional regions","volume":"17","author":"Floettmann","year":"1998","journal-title":"Oncogene"},{"key":"10.1016\/j.pathol.2019.09.005_bib76","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1182\/blood-2007-07-100032","article-title":"The LMP1 oncogene of EBV activates PERK and the unfolded protein response to drive its own synthesis","volume":"111","author":"Lee","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2019.09.005_bib77","doi-asserted-by":"crossref","first-page":"4340","DOI":"10.1182\/blood.V87.10.4340.bloodjournal87104340","article-title":"High-level nuclear NF-kappa B and Oct-2 is a common feature of cultured Hodgkin\/Reed-Sternberg cells","volume":"87","author":"Bargou","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2019.09.005_bib78","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/sj.cgt.7700664","article-title":"A\u00a0strategy for treatment of Epstein-Barr virus-positive Hodgkin's disease by targeting interleukin 12 to the tumor environment using tumor antigen-specific T cells","volume":"11","author":"Wagner","year":"2004","journal-title":"Cancer Gene Ther"},{"key":"10.1016\/j.pathol.2019.09.005_bib79","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1002\/cncr.20188","article-title":"Adoptive immunotherapy with allogeneic Epstein-Barr virus (EBV)-specific cytotoxic T-lymphocytes for recurrent, EBV-positive Hodgkin disease","volume":"100","author":"Lucas","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.pathol.2019.09.005_bib80","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1158\/0008-5472.CAN-03-2196","article-title":"Induction of therapeutic T-cell responses to subdominant tumor-associated viral oncogene after immunization with replication-incompetent polyepitope adenovirus vaccine","volume":"64","author":"Duraiswamy","year":"2004","journal-title":"Cancer Res"},{"key":"10.1016\/j.pathol.2019.09.005_bib81","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1634\/theoncologist.8-1-83","article-title":"Immunotherapy for Epstein-Barr virus-associated cancers in children","volume":"8","author":"Straathof","year":"2003","journal-title":"Oncologist"},{"key":"10.1016\/j.pathol.2019.09.005_bib82","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.jcyt.2018.08.001","article-title":"Epstein-Barr virus (EBV)-derived BARF1 encodes CD4- and CD8-restricted epitopes as targets for T-cell immunotherapy","volume":"21","author":"Kalra","year":"2019","journal-title":"Cytotherapy"},{"key":"10.1016\/j.pathol.2019.09.005_bib83","first-page":"1189","article-title":"Epidemiology of Hodgkin's disease","volume":"26","author":"MacMahon","year":"1966","journal-title":"Cancer Res"},{"key":"10.1016\/j.pathol.2019.09.005_bib84","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/ncb1432","article-title":"The retroviral oncoprotein Tax targets the coiled-coil centrosomal protein TAX1BP2 to induce centrosome overduplication","volume":"8","author":"Ching","year":"2006","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.pathol.2019.09.005_bib85","doi-asserted-by":"crossref","first-page":"9917","DOI":"10.1128\/JVI.73.12.9917-9927.1999","article-title":"Transcriptional up-regulation of the cyclin D2 gene and acquisition of new cyclin-dependent kinase partners in human T-cell leukemia virus type 1-infected cells","volume":"73","author":"Santiago","year":"1999","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.pathol.2019.09.005_bib86","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1182\/blood.V95.1.294","article-title":"Viral latent membrane protein 1 (LMP-1)-induced CD99 down-regulation in B cells leads to the generation of cells with Hodgkin's and Reed-Sternberg phenotype","volume":"95","author":"Kim","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2019.09.005_bib87","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/path.2384","article-title":"The Epstein-Barr virus oncoprotein, latent membrane protein-1, reprograms germinal centre B cells towards a Hodgkin's Reed-Sternberg-like phenotype","volume":"216","author":"Vockerodt","year":"2008","journal-title":"J\u00a0Pathol"},{"key":"10.1016\/j.pathol.2019.09.005_bib88","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1038\/sj.onc.1205215","article-title":"Centrosome overduplication, increased ploidy and transformation in cells expressing endoplasmic reticulum-associated cyclin A2","volume":"21","author":"Faivre","year":"2002","journal-title":"Oncogene"},{"key":"10.1016\/j.pathol.2019.09.005_bib89","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1002\/hep.20615","article-title":"Hepatitis B virus pre-S2 mutant upregulates cyclin A expression and induces nodular proliferation of hepatocytes","volume":"41","author":"Wang","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.pathol.2019.09.005_bib90","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.virol.2006.02.024","article-title":"HPV16 E1--E4 protein is phosphorylated by Cdk2\/cyclin A and relocalizes this complex to the cytoplasm","volume":"349","author":"Davy","year":"2006","journal-title":"Virology"},{"key":"10.1016\/j.pathol.2019.09.005_bib91","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1002\/(SICI)1097-0045(19990215)38:3<175::AID-PROS1>3.0.CO;2-#","article-title":"Expression of cyclin A and D proteins in prostate cancer and their relation to clinopathological variables and patient survival","volume":"38","author":"Aaltomaa","year":"1999","journal-title":"Prostate"},{"key":"10.1016\/j.pathol.2019.09.005_bib92","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1083\/jcb.200701166","article-title":"SCAPER, a novel cyclin A-interacting protein that regulates cell cycle progression","volume":"178","author":"Tsang","year":"2007","journal-title":"J\u00a0Cell Biol"},{"key":"10.1016\/j.pathol.2019.09.005_bib93","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1091\/mbc.01-07-0361","article-title":"Cyclin A- and cyclin E-Cdk complexes shuttle between the nucleus and the cytoplasm","volume":"13","author":"Jackman","year":"2002","journal-title":"Mol Biol Cell"},{"key":"10.1016\/j.pathol.2019.09.005_bib94","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1309\/AJCPBDFR5L5UOAUZ","article-title":"Aberrant expression of cyclin a correlates with morphogenesis of Reed-Sternberg cells in Hodgkin lymphoma","volume":"132","author":"Chang","year":"2009","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.pathol.2019.09.005_bib95","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1093\/carcin\/bgr296","article-title":"Aberrant cyclin A expression and centrosome overduplication induced by hepatitis B virus pre-S2 mutants and its implication in hepatocarcinogenesis","volume":"33","author":"Wang","year":"2012","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.pathol.2019.09.005_bib96","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1309\/33YCNMW08KNA36NT","article-title":"Hodgkin lymphoma involving Waldeyer ring: a clinicopathologic study of 22 cases","volume":"123","author":"Quinones-Avila Mdel","year":"2005","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.pathol.2019.09.005_bib97","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1080\/1042819021000037994","article-title":"New candidate virus in association with Hodgkin's disease","volume":"44","author":"Benharroch","year":"2003","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.pathol.2019.09.005_bib98","first-page":"260","article-title":"Epstein-Barr virus and other candidate viruses in the pathogenesis of Hodgkin's disease","volume":"36","author":"Jarrett","year":"1999","journal-title":"Semin Hematol"},{"key":"10.1016\/j.pathol.2019.09.005_bib99","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1023\/A:1008363805242","article-title":"Discrepancies in Epstein-Barr virus association at presentation and relapse of classical Hodgkin's disease: impact on pathogenesis","volume":"11","author":"Nerurkar","year":"2000","journal-title":"Ann Oncol"},{"key":"10.1016\/j.pathol.2019.09.005_bib100","doi-asserted-by":"crossref","first-page":"4931","DOI":"10.4049\/jimmunol.166.8.4931","article-title":"CD99 signals caspase-independent T cell death","volume":"166","author":"Pettersen","year":"2001","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.pathol.2019.09.005_bib101","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.aanat.2010.07.006","article-title":"3D structural and functional characterization of the transition from Hodgkin to Reed-Sternberg cells","volume":"192","author":"Knecht","year":"2010","journal-title":"Ann Anat"},{"key":"10.1016\/j.pathol.2019.09.005_bib102","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/leu.2008.314","article-title":"The 3D nuclear organization of telomeres marks the transition from Hodgkin to Reed-Sternberg cells","volume":"23","author":"Knecht","year":"2009","journal-title":"Leukemia"},{"key":"10.1016\/j.pathol.2019.09.005_bib103","doi-asserted-by":"crossref","first-page":"E164","DOI":"10.3390\/v9070164","article-title":"LMP1 and dynamic progressive telomere dysfunction: a major culprit in EBV-associated Hodgkin's lymphoma","volume":"9","author":"Knecht","year":"2017","journal-title":"Viruses"},{"key":"10.1016\/j.pathol.2019.09.005_bib104","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1182\/blood-2014-08-594176","article-title":"LMP1 mediates multinuclearity through downregulation of shelterin proteins and formation of telomeric aggregates","volume":"125","author":"Lajoie","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2019.09.005_bib105","first-page":"659","article-title":"Intracellular Compartments and Protein Sorting","author":"Bruce","year":"2002"},{"key":"10.1016\/j.pathol.2019.09.005_bib106","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jchemneu.2004.05.004","article-title":"Survival and apoptosis signals in ER stress: the role of protein kinases","volume":"28","author":"Kadowaki","year":"2004","journal-title":"J\u00a0Chem Neuroanat"},{"key":"10.1016\/j.pathol.2019.09.005_bib107","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1146\/annurev.biochem.73.011303.074134","article-title":"The mammalian unfolded protein response","volume":"74","author":"Schroder","year":"2005","journal-title":"Annu Rev Biochem"},{"key":"10.1016\/j.pathol.2019.09.005_bib108","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jchemneu.2004.02.006","article-title":"The unfolded protein response--a stress signaling pathway of the endoplasmic reticulum","volume":"28","author":"Shen","year":"2004","journal-title":"J\u00a0Chem Neuroanat"},{"key":"10.1016\/j.pathol.2019.09.005_bib109","doi-asserted-by":"crossref","first-page":"9073","DOI":"10.1158\/0008-5472.CAN-05-2016","article-title":"Endoplasmic reticulum stress signal mediators are targets of selenium action","volume":"65","author":"Wu","year":"2005","journal-title":"Cancer Res"},{"key":"10.1016\/j.pathol.2019.09.005_bib110","doi-asserted-by":"crossref","first-page":"10631","DOI":"10.1158\/0008-5472.CAN-07-1705","article-title":"Integrated endoplasmic reticulum stress responses in cancer","volume":"67","author":"Moenner","year":"2007","journal-title":"Cancer Res"},{"key":"10.1016\/j.pathol.2019.09.005_bib111","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S0168-8278(03)00029-1","article-title":"Activation of the ATF6, XBP1 and grp78 genes in human hepatocellular carcinoma: a possible involvement of the ER stress pathway in hepatocarcinogenesis","volume":"38","author":"Shuda","year":"2003","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.pathol.2019.09.005_bib112","doi-asserted-by":"crossref","first-page":"3496","DOI":"10.1158\/0008-5472.CAN-07-0325","article-title":"GRP78 induction in cancer: therapeutic and prognostic implications","volume":"67","author":"Lee","year":"2007","journal-title":"Cancer Res"},{"key":"10.1016\/j.pathol.2019.09.005_bib113","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1038\/cdd.2008.81","article-title":"The unfolded protein response regulator GRP78\/BiP is required for endoplasmic reticulum integrity and stress-induced autophagy in mammalian cells","volume":"15","author":"Li","year":"2008","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.pathol.2019.09.005_bib114","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.canlet.2008.07.005","article-title":"Endoplasmic reticulum stress and autophagy as targets for cancer therapy","volume":"275","author":"Schonthal","year":"2009","journal-title":"Cancer Lett"},{"key":"10.1016\/j.pathol.2019.09.005_bib115","doi-asserted-by":"crossref","first-page":"5363","DOI":"10.1158\/0008-5472.CAN-08-0035","article-title":"Increasing melanoma cell death using inhibitors of protein disulfide isomerases to abrogate survival responses to endoplasmic reticulum stress","volume":"68","author":"Lovat","year":"2008","journal-title":"Cancer Res"},{"key":"10.1016\/j.pathol.2019.09.005_bib116","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.taap.2015.07.026","article-title":"Oroxin B selectively induces tumor-suppressive ER stress and concurrently inhibits tumor-adaptive ER stress in B-lymphoma cells for effective anti-lymphoma therapy","volume":"288","author":"Yang","year":"2015","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.pathol.2019.09.005_bib117","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1126\/science.1081208","article-title":"BAX and BAK regulation of endoplasmic reticulum Ca2+: a control point for apoptosis","volume":"300","author":"Scorrano","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.pathol.2019.09.005_bib118","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.humpath.2006.06.017","article-title":"Expression of bcl2 family proteins and active caspase 3 in classical Hodgkin's lymphomas","volume":"38","author":"Bai","year":"2007","journal-title":"Hum Pathol"},{"key":"10.1016\/j.pathol.2019.09.005_bib119","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.0309-0167.2004.01829.x","article-title":"Expression of Bcl-2 family members and presence of Epstein-Barr virus in the regulation of cell growth and death in classical Hodgkin's lymphoma","volume":"44","author":"Kim","year":"2004","journal-title":"Histopathology"},{"key":"10.1016\/j.pathol.2019.09.005_bib120","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1002\/path.1151","article-title":"Vascular endothelial growth factor (VEGF) is expressed by neoplastic Hodgkin-Reed-Sternberg cells in Hodgkin's disease","volume":"197","author":"Doussis-Anagnostopoulou","year":"2002","journal-title":"J\u00a0Pathol"},{"key":"10.1016\/j.pathol.2019.09.005_bib121","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1002\/path.1900","article-title":"The expression of fibroblast growth factors and their receptors in Hodgkin's lymphoma","volume":"208","author":"Khnykin","year":"2006","journal-title":"J\u00a0Pathol"},{"key":"10.1016\/j.pathol.2019.09.005_bib122","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.1182\/blood-2004-09-3759","article-title":"Impact of tumor Epstein-Barr virus status on presenting features and outcome in age-defined subgroups of patients with classic Hodgkin lymphoma: a population-based study","volume":"106","author":"Jarrett","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2019.09.005_bib123","doi-asserted-by":"crossref","first-page":"3815","DOI":"10.1200\/JCO.2008.20.5138","article-title":"Latent Epstein-Barr virus infection of tumor cells in classical Hodgkin's lymphoma predicts adverse outcome in older adult patients","volume":"27","author":"Diepstra","year":"2009","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.pathol.2019.09.005_bib124","doi-asserted-by":"crossref","first-page":"7604","DOI":"10.1200\/JCO.2005.02.6310","article-title":"Epstein-Barr virus as a marker of survival after Hodgkin's lymphoma: a population-based study","volume":"23","author":"Keegan","year":"2005","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.pathol.2019.09.005_bib125","doi-asserted-by":"crossref","first-page":"3339","DOI":"10.1182\/blood-2008-01-134783","article-title":"Aberrant expression of the Th2 cytokine IL-21 in Hodgkin lymphoma cells regulates STAT3 signaling and attracts Treg cells via regulation of MIP-3alpha","volume":"112","author":"Lamprecht","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2019.09.005_bib126","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1002\/path.2711","article-title":"The classical Hodgkin's lymphoma microenvironment and its role in promoting tumour growth and immune escape","volume":"221","author":"Aldinucci","year":"2010","journal-title":"J\u00a0Pathol"},{"key":"10.1016\/j.pathol.2019.09.005_bib127","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.1038\/sj.leu.2403123","article-title":"Increased serum levels of interleukin-9 correlate to negative prognostic factors in Hodgkin's lymphoma","volume":"17","author":"Fischer","year":"2003","journal-title":"Leukemia"},{"key":"10.1016\/j.pathol.2019.09.005_bib128","first-page":"2118","article-title":"Serum interleukin 6 levels are elevated in lymphoma patients and correlate with survival in advanced Hodgkin's disease and with B symptoms","volume":"53","author":"Kurzrock","year":"1993","journal-title":"Cancer Res"},{"key":"10.1016\/j.pathol.2019.09.005_bib129","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/bjh.12759","article-title":"Current status of prognostication in classical Hodgkin lymphoma","volume":"165","author":"Venkataraman","year":"2014","journal-title":"Br J Haematol"},{"key":"10.1016\/j.pathol.2019.09.005_bib130","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/s41408-019-0195-7","article-title":"Genomic analyses of microdissected Hodgkin and Reed-Sternberg cells: mutations in epigenetic regulators and p53 are frequent in refractory classic Hodgkin lymphoma","volume":"9","author":"Mata","year":"2019","journal-title":"Blood Cancer J"},{"key":"10.1016\/j.pathol.2019.09.005_bib131","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1093\/ajcp\/98.3.319","article-title":"Influence of Epstein-Barr virus genomes on patient survival in Hodgkin's disease","volume":"98","author":"Fellbaum","year":"1992","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.pathol.2019.09.005_bib132","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/0046-8177(95)90064-0","article-title":"Detection of Epstein-Barr virus in Hodgkin's disease occurring in an Oriental population","volume":"26","author":"Chan","year":"1995","journal-title":"Hum Pathol"},{"key":"10.1016\/j.pathol.2019.09.005_bib133","first-page":"115","article-title":"Hodgkin's disease in the Philippines","volume":"9","author":"Paulino","year":"1996","journal-title":"Mod Pathol"},{"key":"10.1016\/j.pathol.2019.09.005_bib134","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1093\/ajcp\/109.5.618","article-title":"Hodgkin's disease in Costa Rica: a report of 40 cases analyzed for Epstein-Barr virus","volume":"109","author":"Monterroso","year":"1998","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.pathol.2019.09.005_bib135","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1002\/1097-0142(19950315)75:6<1360::AID-CNCR2820750619>3.0.CO;2-U","article-title":"Hodgkin's disease in Mexico. Prevalence of Epstein-Barr virus sequences and correlations with histologic subtype","volume":"75","author":"Zarate-Osorno","year":"1995","journal-title":"Cancer"},{"key":"10.1016\/j.pathol.2019.09.005_bib136","first-page":"675","article-title":"Association of Epstein-Barr virus latent membrane protein and Hodgkin's disease in Mexico","volume":"8","author":"Quintanilla-Martinez","year":"1995","journal-title":"Mod Pathol"},{"key":"10.1016\/j.pathol.2019.09.005_bib137","doi-asserted-by":"crossref","first-page":"3828","DOI":"10.1182\/blood.V87.9.3828.bloodjournal8793828","article-title":"The consistent association between Epstein-Barr virus and Hodgkin's disease in children in Kenya","volume":"87","author":"Weinreb","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2019.09.005_bib138","first-page":"177","article-title":"Nodular paragranuloma and Epstein-Barr virus: frequency of EBV DNA and clinical relevance. (German)","volume":"76","author":"Rohde","year":"1992","journal-title":"Verh Dtsch Ges Pathol"}],"container-title":["Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031302519303952?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031302519303952?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,1,27]],"date-time":"2021-01-27T04:18:02Z","timestamp":1611721082000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0031302519303952"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":138,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["S0031302519303952"],"URL":"https:\/\/doi.org\/10.1016\/j.pathol.2019.09.005","relation":{},"ISSN":["0031-3025"],"issn-type":[{"value":"0031-3025","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hodgkin lymphoma: a review of pathological features and recent advances in pathogenesis","name":"articletitle","label":"Article Title"},{"value":"Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pathol.2019.09.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Royal College of Pathologists of Australasia. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}